Mereo Biopharma Group Plc MREO Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$0.28 up $0.00, 0.93% at close Nov 6
Last close · Previous close $0.28
- Market cap
- $45.17MAt the Nov 6 close
- P/E ratio
- On last 12 months’ EPS
- Diluted EPS
- Last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$0.28down $0.07, 19.17%Past month
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$0.28Nov 5
- Volume655.62KNov 6 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume643.05KLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $0.20 to $2.37; now $0.28
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Nov 6 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
MREO trailed the S&P 500 in all 6 periods.
| Period | MREO and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | MREO: down 19.2% S&P 500: down 5.6% | MREO trailed the S&P 500 by 13.6 percentage points Trailed |
| 3M | MREO: down 7.5% S&P 500: down 4.1% | MREO trailed the S&P 500 by 3.4 percentage points Trailed |
| YTD | MREO: down 32.1% S&P 500: up 8.7% | MREO trailed the S&P 500 by 40.8 percentage points Trailed |
| 1Y | MREO: down 83.9% S&P 500: up 10.9% | MREO trailed the S&P 500 by 94.8 percentage points Trailed |
| Long term | ||
| 3Y | MREO: down 86.3% S&P 500: up 75.0% −48.5% vs +20.5% a year | MREO trailed the S&P 500 by 161.3 percentage points Trailed |
| 5Y | MREO: down 88.3% S&P 500: up 67.8% −34.9% vs +10.9% a year | MREO trailed the S&P 500 by 156.1 percentage points Trailed |
$10,000 invested in MREO 5 years ago (Nov 5, 2021) would be worth about $1,169 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $16,782.
MREO trailed the S&P 500 in all 6 periods.
| Period | MREO and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | MREO: down 19.2% S&P 500: down 5.6% | MREO trailed the S&P 500 by 13.6 percentage points Trailed |
| 3M | MREO: down 7.5% S&P 500: down 4.3% | MREO trailed the S&P 500 by 3.2 percentage points Trailed |
| YTD | MREO: down 32.1% S&P 500: up 7.8% | MREO trailed the S&P 500 by 39.9 percentage points Trailed |
| 1Y | MREO: down 83.9% S&P 500: up 9.7% | MREO trailed the S&P 500 by 93.6 percentage points Trailed |
| Long term | ||
| 3Y | MREO: down 86.3% S&P 500: up 68.8% −48.5% vs +19.1% a year | MREO trailed the S&P 500 by 155.1 percentage points Trailed |
| 5Y | MREO: down 88.3% S&P 500: up 56.9% −34.9% vs +9.4% a year | MREO trailed the S&P 500 by 145.2 percentage points Trailed |
$10,000 invested in MREO 5 years ago (Nov 5, 2021) would be worth about $1,169 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $15,694.
All-time high
$6.50
Closing high on . Now 95.6% below that record.
Split-adjusted daily closes since Apr 24, 2019.
Stock splits
MREO hasn’t split since its price history begins in 2019.
Valuation
Financials
About Mereo Biopharma Group Plc
Mereo BioPharma Group plc
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- United Kingdom
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
MREO news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
MREO stock FAQ
What is MREO stock’s price today?
Mereo Biopharma Group (MREO) traded at $0.28 at the close on , unchanged from the previous close of $0.28. Over the past 52 weeks it has traded between $0.20 and $2.37.
If you invested $1,000 in MREO 5 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in MREO on would be worth about $117 at the close on , a total return of −88.3%. The same $1,000 would be worth $161 if invested one year ago. Past performance doesn’t predict future returns.
What is Mereo Biopharma Group’s market cap?
Mereo Biopharma Group’s market capitalization is about $45.2 million. That’s Tiingo’s daily market cap for , at that day’s closing price of $0.28 (how market cap works).
Does MREO pay a dividend?
Mereo Biopharma Group hasn’t paid a dividend in the last twelve months.
What is MREO’s 52-week high and low?
Over the past 52 weeks MREO has traded as low as $0.20 and as high as $2.37. At $0.28 at the close on , it is 88.1% below that high and 41.5% above the low.
What is MREO’s all-time high?
MREO’s highest closing price was $6.50 on , adjusted for stock splits. At $0.28 at the close on , it is 95.6% below that record.
Has MREO stock ever split?
No. MREO hasn’t split since its price history begins in 2019.
How has MREO stock performed?
Including dividends and measured to the close on , MREO has returned −32.1% so far this year and −83.9% over the past year, and −88.3% over five years (−34.9% a year). Over the same periods the S&P 500, measured by SPY, returned +8.7%, +10.9% and +67.8%. Past performance doesn’t predict future returns.
What sector and industry is Mereo Biopharma Group in?
Mereo Biopharma Group is in the Healthcare sector and the Biotechnology industry, and is headquartered in United Kingdom.
What exchange does MREO trade on?
Mereo Biopharma Group trades on the Nasdaq under the ticker symbol MREO. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.